Counterfeit drug revenues are estimated to be in the region of $75 Billion in 2010 and are projected to grow at 13% annually. The World Health Organisation states that it is impossible to quantify the size of the problem but that it may be as much as 10% of the global market. (more…)
Archive for the ‘PRISYM Medica’ Category
Mar 22nd
PRISYM Medica
PRISYM Medica is a purpose designed labeling software solution for Life Science organizations specifically developed to meet the FDA‘s current 21 CFR Part 11 compliance requirements. PRISYM Medica is supplied as a validated labeling solution including auditable security protocols and lifecycle documentation based on the GAMP V Model. (more…)
May 1st
Threat From Generics Increases Brand Focus
As pressure from generics increases, companies are starting to appreciate the value of brand loyalty. There will always be some consumers that buy on price but for many a name you can trust is still important. (more…)
